SHARE CAPITAL | 11. SHARE CAPITAL 11.1 Authorized 11.2 Issued and Outstanding Common Shares: The details for the common share issuances during the nine months ended September 30, 2023 are as follows: a. During the nine months ended September 30, 2023, the Company issued 925,667 44 823 The details for the common share issuances during the nine months ended September 30, 2022 were as follows: b. During the nine months ended September 30, 2022, 4,444,445 12,000 1,283 During the nine months ended September 30, 2022, the Company also issued 302,555 988 c. During the nine months ended September 30, 2022, 66,661 75 11.3 Share Purchase Warrants A summary of the Company’s share purchase warrants are as follows: Schedule of Share Purchase Units Number of Warrants Weighted Average Exercise Price C$ Outstanding, December 31, 2021 2,407,304 6.64 Issued 5,577,778 3.84 Cancelled (412,000 ) — Outstanding, December 31, 2022 7,573,082 4.53 Cancelled (1,000,000 ) — Issued 1,500,000 1.33 Outstanding, September 30, 2023 8,073,082 4.22 During the nine months ended September 30, 2023, the Company issued 1,500,000 1,000,000 During the nine months ended September 30, 2022, the Company issued 4,444,445 133,333 During the nine months ended September 30, 2022, the Company issued 1,000,000 11.4 Directors, Consultants, and Employee stock options The Company has adopted a share option plan for which options to acquire up to a total of 10% of the issued share capital, at the award date, may be granted to eligible optionees from time to time. Generally, share options granted have a maximum term of five years, and a vesting period and exercise price determined by the directors. During the nine months ended September 30, 2022, the Company granted 290,000 During the nine months ended September 30, 2023, the Company recognized $39 (September 30, 2022 - $56) on the grant and vesting of options to directors, consultants and employees. The following tables summarize information about the Company’s stock options outstanding at September 30, 2023: Schedule of stock options outstanding Options Outstanding Options Exercisable Exercise Remaining Contractual Life (Years) Expiry Date C$ January 17, 2019 166,666 166,666 2.40 0.30 January 17, 2024 November 15, 2019 233,333 233,333 1.50 1.13 November 15, 2024 November 28, 2019 16,666 16,666 1.56 1.16 November 28, 2024 May 4, 2020 24,999 24,999 1.20 1.59 May 4, 2025 November 23, 2020 66,664 66,664 6.15 2.15 November 23, 2025 January 12, 2021 333,333 333,333 6.51 2.28 January 11, 2026 February 1, 2021 41,666 41,666 9.36 2.34 January 31, 2026 April 27, 2021 60,000 40,000 7.24 2.57 April 26, 2026 March 31, 2022 40,000 20,000 2.98 3.50 March 30, 2027 November 25, 2022 92,500 15,417 1.30 4.15 November 24, 2027 Total 1,075,827 958,744 During the nine months ended September 30, 2023, 504,999 11.5 Deferred Share Units Pursuant to the Company’s Deferred Share Unit (“DSU”) Incentive Plan approved by the board of directors of the Company on July 8, 2018, deferred stock units to acquire common shares of the Company may be granted to specified board members of the Company in accordance with the terms and conditions of the plan. Each DSU entitles the participant to receive one common share upon vesting. DSUs vest into common shares on the board members’ separation date from the board of directors. DSUs track the value of the underlying common shares, but do not entitle the recipient to the underlying common shares until such DSUs vest, nor do they entitle a holder to exercise voting rights or any other rights attached to ownership or control of the common shares, until the DSU vests and the DSU participant receives common shares. A summary of the Company’s DSUs are as follows: Schedule of deferred share units Number of DSUs Outstanding, December 31, 2021 170,791 Issued 452,910 Outstanding, December 31, 2022 623,701 Issued 492,757 Outstanding, September 30, 2023 1,116,458 During the nine months ended September 30, 2023, the Company issued 492,757 DSUs (September 30, 2022 – 304,473) to board members of the Company that vest upon the board members separation date from the Board of Directors. During the nine months ended September 30, 2023, the Company recorded $420 (September 30, 2022 - $426) as stock-based compensation for the fair value of the DSUs issued. |